Stacy Dobbs Email

VP Financial Planning Analysis . Editas Medicine

Current Roles

Employees:
271
Revenue:
$24.5M
About
Unlocking the Promise of Genome Editing to Deliver Life-Changing Medicines. As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Editas Medicine Address
11 Hurley St
Cambridge, MA
United States
Editas Medicine Email

Past Companies

Editas MedicineVice President of Financial Planning Analysis
Editas MedicineSenior Director Financial Planning Analysis
bluebird bioSenior Director Financial Planning Analysis

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.